Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Bouffard AA"'
Autor:
Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2286.
Autor:
Grauwet K; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Berger T; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA., Kann MC; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA., Silva H; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA., Larson R; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Leick MB; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Bailey SR; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Bouffard AA; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA., Millar D; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Gallagher K; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Turtle CJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Frigault MJ; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Maus MV; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 09; Vol. 12 (5). Date of Electronic Publication: 2024 May 09.
Autor:
Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Guinn S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Birocchi F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kuo A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Sun Y; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Almazan AJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Anekal PV; MicRoN Core, Harvard Medical School, Boston, Massachusetts., Montero Llopis P; MicRoN Core, Harvard Medical School, Boston, Massachusetts., Nieman LT; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Song Y; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Xu KH; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Silva H; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Salas-Benito D; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kienka T; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Armstrong TD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Zhang R; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Zhu Q; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Fu J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Korell F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Choi BD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Liss AS; Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Boland GM; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Ting DT; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Burkhart RA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Jenkins RW; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Zheng L; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Jaffee EM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Zimmerman JW; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1859-1877.
Autor:
Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Schneider EM; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Almazan AJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Lane IC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Supper VM; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Takei HN; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Tepper A; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Blood and Bone Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA., Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ebert BL; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Howard Hughes Medical Institute, Bethesda, MD, USA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA. mvmaus@mgh.harvard.edu., Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 590-600. Date of Electronic Publication: 2023 Dec 20.
Autor:
Lane IC; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Kembuan G; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Carreiro J; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kann MC; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Lin W; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Bouffard AA; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Kreuzer J; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Morris R; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Schneider EM; Harvard Medical School, Boston, MA, USA., Kim JY; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zou C; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Salas-Benito D; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Gasser JA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leick MB; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Słabicki M; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Haas W; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Maus MV; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Jan M; Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: mjan@mgh.harvard.edu.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2024 Feb 15; Vol. 31 (2), pp. 338-348.e5. Date of Electronic Publication: 2023 Nov 20.
Autor:
Larson RC; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Kann MC; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Graham C; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Mount CW; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Castano AP; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Lee WH; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Bouffard AA; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Takei HN; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Almazan AJ; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Scarfó I; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Berger TR; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Schmidts A; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Frigault MJ; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Gallagher KME; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 18; Vol. 14 (1), pp. 7509. Date of Electronic Publication: 2023 Nov 18.
Autor:
Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Srivastava AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Ramapriyan R; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Carter BS; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Curry WT; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Dunn GP; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Gerstner ER; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA (E.R.G.)., Ghannam JY; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Nahed BV; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Richardson LG; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Sun J; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Choi BD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2022 Dec 22; Vol. 5 (1), pp. vdac185. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2023).
Autor:
Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA., Silva H; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Larson R; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Choi BD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA., Gallagher K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA., Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA., Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA., Horick N; Department of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mvmaus@mgh.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2022 May 09; Vol. 40 (5), pp. 494-508.e5. Date of Electronic Publication: 2022 Apr 21.
Autor:
Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Haradhvala NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Graduate Program in Biophysics, Harvard University, Cambridge, MA, USA., Llopis PM; MicRoN Core, Harvard Medical School, Boston, MA, USA., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Scarfó I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Stewart K; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Anekal PV; MicRoN Core, Harvard Medical School, Boston, MA, USA., Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Joung J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Brain and Cognitive Science, MIT, Cambridge, MA, USA.; Department of Biological Engineering, MIT, Cambridge, MA, USA.; McGovern Institute for Brain Research at MIT, Cambridge, MA, USA.; Howard Hughes Medical Institute, MIT, Cambridge, MA, USA., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Ouspenskaia T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Law T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Regev A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biology and Koch Institute of Integrative Cancer Research, MIT, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA., Getz G; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. mvmaus@mgh.harvard.edu.
Publikováno v:
Nature [Nature] 2022 Apr; Vol. 604 (7906), pp. 563-570. Date of Electronic Publication: 2022 Apr 13.
Autor:
Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Vatsa S; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts., Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Silva H; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Lindell KA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Demato A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Gallagher KME; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2022 Mar 01; Vol. 3 (2), pp. 136-153.